News
Cosmo today announced the signing of an agreement to sell “Digital Trust” to its existing customer Tinexta InfoCert, Europe’s largest Certification Authority and a subsidiary of Tinexta S.p.A., a ...
India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's Mounjaro, which gained early traction. Both drugs address rising obesity and ...
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
Sun Pharmaceutical Industries Ltd. closed 15.25% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...
1don MSNOpinion
India's pharma sector is poised for innovation-led growth, fueled by patent expirations and government support. The ₹5,000-cr ...
ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...
Corona Remedies Limited appoints four independent directors with diverse expertise in pharmaceutical formulation and ...
Jammu: In a special drive aimed at curbing the misuse of pharmaceuticals with habit forming ingredients, authorities in Jammu ...
Sun Pharmaceutical Industries Ltd. closed 15.23% short of its 52-week high of 1,960.20 rupees, which the company reached on ...
The global moringa products market is projected to be valued at USD 9.3 billion in 2025 and is anticipated to reach USD 23 ...
Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on their medicine for a while but struggle down the road.
The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results